Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion
Identifieur interne : 000375 ( Istex/Corpus ); précédent : 000374; suivant : 000376Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion
Auteurs : Alessandro Testori ; Cornelis Verhoef ; Hidde M. Kroon ; E. Pennacchioli ; Mark B. Faries ; Alexander M. M. Eggermont ; John F. ThompsonSource :
- Journal of Surgical Oncology [ 0022-4790 ] ; 2011-09-15.
Abstract
In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/jso.22028
Links to Exploration step
ISTEX:085ABF07F0C369C4798C9F363CFBF1379CD2546FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title><author><name sortKey="Testori, Alessandro" sort="Testori, Alessandro" uniqKey="Testori A" first="Alessandro" last="Testori">Alessandro Testori</name><affiliation><mods:affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</mods:affiliation></affiliation></author><author><name sortKey="Verhoef, Cornelis" sort="Verhoef, Cornelis" uniqKey="Verhoef C" first="Cornelis" last="Verhoef">Cornelis Verhoef</name><affiliation><mods:affiliation>Erasmus University MC, Rotterdam, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kroon, Hidde M" sort="Kroon, Hidde M" uniqKey="Kroon H" first="Hidde M." last="Kroon">Hidde M. Kroon</name><affiliation><mods:affiliation>Rijnland Hospital, Leiderdorp, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Pennacchioli, E" sort="Pennacchioli, E" uniqKey="Pennacchioli E" first="E." last="Pennacchioli">E. Pennacchioli</name><affiliation><mods:affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Faries, Mark B" sort="Faries, Mark B" uniqKey="Faries M" first="Mark B." last="Faries">Mark B. Faries</name><affiliation><mods:affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut</mods:affiliation></affiliation></author><author><name sortKey="Eggermont, Alexander M M" sort="Eggermont, Alexander M M" uniqKey="Eggermont A" first="Alexander M. M." last="Eggermont">Alexander M. M. Eggermont</name><affiliation><mods:affiliation>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France</mods:affiliation></affiliation></author><author><name sortKey="Thompson, John F" sort="Thompson, John F" uniqKey="Thompson J" first="John F." last="Thompson">John F. Thompson</name><affiliation><mods:affiliation>Melanoma Institute Australia, North Sydney, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>University of Sydney, Sydney, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:085ABF07F0C369C4798C9F363CFBF1379CD2546F</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/jso.22028</idno><idno type="url">https://api.istex.fr/document/085ABF07F0C369C4798C9F363CFBF1379CD2546F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000375</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000375</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title><author><name sortKey="Testori, Alessandro" sort="Testori, Alessandro" uniqKey="Testori A" first="Alessandro" last="Testori">Alessandro Testori</name><affiliation><mods:affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</mods:affiliation></affiliation></author><author><name sortKey="Verhoef, Cornelis" sort="Verhoef, Cornelis" uniqKey="Verhoef C" first="Cornelis" last="Verhoef">Cornelis Verhoef</name><affiliation><mods:affiliation>Erasmus University MC, Rotterdam, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kroon, Hidde M" sort="Kroon, Hidde M" uniqKey="Kroon H" first="Hidde M." last="Kroon">Hidde M. Kroon</name><affiliation><mods:affiliation>Rijnland Hospital, Leiderdorp, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Pennacchioli, E" sort="Pennacchioli, E" uniqKey="Pennacchioli E" first="E." last="Pennacchioli">E. Pennacchioli</name><affiliation><mods:affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Faries, Mark B" sort="Faries, Mark B" uniqKey="Faries M" first="Mark B." last="Faries">Mark B. Faries</name><affiliation><mods:affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut</mods:affiliation></affiliation></author><author><name sortKey="Eggermont, Alexander M M" sort="Eggermont, Alexander M M" uniqKey="Eggermont A" first="Alexander M. M." last="Eggermont">Alexander M. M. Eggermont</name><affiliation><mods:affiliation>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France</mods:affiliation></affiliation></author><author><name sortKey="Thompson, John F" sort="Thompson, John F" uniqKey="Thompson J" first="John F." last="Thompson">John F. Thompson</name><affiliation><mods:affiliation>Melanoma Institute Australia, North Sydney, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>University of Sydney, Sydney, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Surgical Oncology</title><title level="j" type="sub">Seminars in Surgical Oncology: Melanoma</title><title level="j" type="alt">JOURNAL OF SURGICAL ONCOLOGY</title><idno type="ISSN">0022-4790</idno><idno type="eISSN">1096-9098</idno><imprint><biblScope unit="vol">104</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="397">397</biblScope><biblScope unit="page" to="404">404</biblScope><biblScope unit="page-count">8</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09-15">2011-09-15</date></imprint><idno type="ISSN">0022-4790</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-4790</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>melanoma</json:string><json:string>melphalan</json:string><json:string>limb perfusion</json:string><json:string>surg</json:string><json:string>oncol</json:string><json:string>perfusion</json:string><json:string>limb infusion</json:string><json:string>toxicity</json:string><json:string>metastasis</json:string><json:string>kroon</json:string><json:string>infusion</json:string><json:string>sarcoma</json:string><json:string>surg oncol</json:string><json:string>hyperthermic</json:string><json:string>limb</json:string><json:string>oncology</json:string><json:string>clin</json:string><json:string>beasley</json:string><json:string>cytotoxic</json:string><json:string>eggermont</json:string><json:string>hyperthermia</json:string><json:string>multicenter</json:string><json:string>tourniquet</json:string><json:string>clin oncol</json:string><json:string>lienard</json:string><json:string>melanoma metastases</json:string><json:string>malignant melanoma</json:string><json:string>surgical</json:string><json:string>surgical oncology</json:string><json:string>tumor necrosis</json:string><json:string>tumor necrosis factor</json:string><json:string>melanoma patients</json:string><json:string>systemic toxicity</json:string><json:string>cytotoxic drugs</json:string><json:string>arch surg</json:string><json:string>leakage</json:string><json:string>clinical response</json:string><json:string>best response</json:string><json:string>clinical result</json:string><json:string>soft tissue sarcomas</json:string><json:string>pneumatic tourniquet</json:string><json:string>interferon gamma</json:string><json:string>extracorporeal circuit</json:string><json:string>limb perfusions</json:string><json:string>response rates</json:string><json:string>necrosis</json:string></teeft></keywords><author><json:item><name>Alessandro Testori MD</name><affiliations><json:string>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</json:string><json:string>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</json:string></affiliations></json:item><json:item><name>Cornelis Verhoef MD, PhD</name><affiliations><json:string>Erasmus University MC, Rotterdam, the Netherlands</json:string></affiliations></json:item><json:item><name>Hidde M. Kroon MD</name><affiliations><json:string>Rijnland Hospital, Leiderdorp, the Netherlands</json:string></affiliations></json:item><json:item><name>E. Pennacchioli MD</name><affiliations><json:string>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</json:string></affiliations></json:item><json:item><name>Mark B. Faries MD</name><affiliations><json:string>Department of Surgery, Yale School of Medicine, New Haven, Connecticut</json:string></affiliations></json:item><json:item><name>Alexander M.M. Eggermont MD</name><affiliations><json:string>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France</json:string></affiliations></json:item><json:item><name>John F. Thompson MD</name><affiliations><json:string>Melanoma Institute Australia, North Sydney, Australia</json:string><json:string>University of Sydney, Sydney, Australia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>melanoma in‐transit metastases</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>isolated limb perfusion</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>isolated limb infusion</value></json:item></subject><articleId><json:string>JSO22028</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.</abstract><qualityIndicators><score>5.456</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>261</abstractCharCount><pdfWordCount>5122</pdfWordCount><pdfCharCount>32299</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>38</abstractWordCount></qualityIndicators><title>Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title><genre><json:string>review-article</json:string></genre><host><title>Journal of Surgical Oncology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1096-9098</json:string></doi><issn><json:string>0022-4790</json:string></issn><eissn><json:string>1096-9098</json:string></eissn><publisherId><json:string>JSO</json:string></publisherId><volume>104</volume><issue>4</issue><pages><first>397</first><last>404</last><total>8</total></pages><genre><json:string>journal</json:string></genre><author><json:item><name>Don Morton</name><affiliations><json:string>John Wayne Cancer Institute Santa Monica, CA</json:string></affiliations></json:item></author><subject><json:item><value>Review Article</value></json:item></subject></host><categories><wos><json:string>science</json:string><json:string>surgery</json:string><json:string>oncology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>oncology & carcinogenesis</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string><json:string>nephrologie. maladies des voies urinaires</json:string></inist></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1002/jso.22028</json:string></doi><id>085ABF07F0C369C4798C9F363CFBF1379CD2546F</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/085ABF07F0C369C4798C9F363CFBF1379CD2546F/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/085ABF07F0C369C4798C9F363CFBF1379CD2546F/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/085ABF07F0C369C4798C9F363CFBF1379CD2546F/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title></titleStmt><publicationStmt><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><licence>Copyright © 2011 Wiley‐Liss, Inc.</licence></availability><date type="published" when="2011-09-15"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main" xml:lang="en">Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title><title level="a" type="short" xml:lang="en">Locoregional Treatment of Melanoma</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Alessandro</forename><surname>Testori</surname><roleName type="degree">MD</roleName></persName><email>alessandro.testori@ieo.it</email><affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy<address><country key="IT"></country></address></affiliation><affiliation>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Cornelis</forename><surname>Verhoef</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Erasmus University MC, Rotterdam, the Netherlands<address><country key="NL"></country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Hidde M.</forename><surname>Kroon</surname><roleName type="degree">MD</roleName></persName><affiliation>Rijnland Hospital, Leiderdorp, the Netherlands<address><country key="NL"></country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">E.</forename><surname>Pennacchioli</surname><roleName type="degree">MD</roleName></persName><affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Mark B.</forename><surname>Faries</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut<address><country key="US"></country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Alexander M.M.</forename><surname>Eggermont</surname><roleName type="degree">MD</roleName></persName><affiliation>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France<address><country key="FR"></country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">John F.</forename><surname>Thompson</surname><roleName type="degree">MD</roleName></persName><affiliation>Melanoma Institute Australia, North Sydney, Australia<address><country key="AU"></country></address></affiliation><affiliation>University of Sydney, Sydney, Australia<address><country key="AU"></country></address></affiliation></author><idno type="istex">085ABF07F0C369C4798C9F363CFBF1379CD2546F</idno><idno type="DOI">10.1002/jso.22028</idno><idno type="unit">JSO22028</idno><idno type="toTypesetVersion">file:JSO.JSO22028.pdf</idno></analytic><monogr><title level="j" type="main">Journal of Surgical Oncology</title><title level="j" type="sub">Seminars in Surgical Oncology: Melanoma</title><title level="j" type="alt">JOURNAL OF SURGICAL ONCOLOGY</title><idno type="pISSN">0022-4790</idno><idno type="eISSN">1096-9098</idno><idno type="book-DOI">10.1002/(ISSN)1096-9098</idno><idno type="book-part-DOI">10.1002/jso.v104.4</idno><idno type="product">JSO</idno><imprint><biblScope unit="vol">104</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="397">397</biblScope><biblScope unit="page" to="404">404</biblScope><biblScope unit="page-count">8</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09-15"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="kwd1">melanoma in‐transit metastases</term><term xml:id="kwd2">isolated limb perfusion</term><term xml:id="kwd3">isolated limb infusion</term></keywords><classCode scheme="articleCategory">Review Article</classCode><classCode scheme="tocHeading1">Review Articles</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/085ABF07F0C369C4798C9F363CFBF1379CD2546F/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1096-9098</doi><issn type="print">0022-4790</issn><issn type="electronic">1096-9098</issn><idGroup><id type="product" value="JSO"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="JOURNAL OF SURGICAL ONCOLOGY">Journal of Surgical Oncology</title><title type="short">J. Surg. Oncol.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/jso.v104.4</doi><titleGroup><title type="specialIssueTitle">Seminars in Surgical Oncology: Melanoma</title></titleGroup><numberingGroup><numbering type="journalVolume" number="104">104</numbering><numbering type="journalIssue">4</numbering></numberingGroup><creators><creator xml:id="sped1" creatorRole="sponsoringEditor" affiliationRef="#sp1"><personName><givenNames>Don</givenNames><familyName>Morton</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="sp1" countryCode="CA" type="organization"><unparsedAffiliation>John Wayne Cancer Institute Santa Monica, CA</unparsedAffiliation></affiliation></affiliationGroup><coverDate startDate="2011-09-15">15 September 2011</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="100" status="forIssue"><doi origin="wiley" registered="yes">10.1002/jso.22028</doi><idGroup><id type="unit" value="JSO22028"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Review Article</title><title type="tocHeading1">Review Articles</title></titleGroup><copyright ownership="publisher">Copyright © 2011 Wiley‐Liss, Inc.</copyright><eventGroup><event type="manuscriptReceived" date="2011-06-20"></event><event type="manuscriptAccepted" date="2011-06-21"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:3.3.3 mode:FullText" date="2014-08-12"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.3.3 mode:FullText" date="2014-08-12"></event><event type="publishedOnlineFinalForm" date="2011-08-19"></event><event type="firstOnline" date="2011-08-19"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event></eventGroup><numberingGroup><numbering type="pageFirst">397</numbering><numbering type="pageLast">404</numbering></numberingGroup><correspondenceTo>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JSO.JSO22028.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="4"></count><count type="tableTotal" number="4"></count><count type="referenceTotal" number="69"></count><count type="wordTotal" number="6479"></count></countGroup><titleGroup><title type="main" xml:lang="en">Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title><title type="short" xml:lang="en">Locoregional Treatment of Melanoma</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Alessandro</givenNames><familyName>Testori</familyName><degrees>MD</degrees></personName><contactDetails><email>alessandro.testori@ieo.it</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Cornelis</givenNames><familyName>Verhoef</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Hidde M.</givenNames><familyName>Kroon</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>E.</givenNames><familyName>Pennacchioli</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Mark B.</givenNames><familyName>Faries</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Alexander M.M.</givenNames><familyName>Eggermont</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af6 #af7"><personName><givenNames>John F.</givenNames><familyName>Thompson</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="IT" type="organization"><unparsedAffiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="NL" type="organization"><unparsedAffiliation>Erasmus University MC, Rotterdam, the Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="NL" type="organization"><unparsedAffiliation>Rijnland Hospital, Leiderdorp, the Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="FR" type="organization"><unparsedAffiliation>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="AU" type="organization"><unparsedAffiliation>Melanoma Institute Australia, North Sydney, Australia</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="AU" type="organization"><unparsedAffiliation>University of Sydney, Sydney, Australia</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">melanoma in‐transit metastases</keyword><keyword xml:id="kwd2">isolated limb perfusion</keyword><keyword xml:id="kwd3">isolated limb infusion</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Locoregional Treatment of Melanoma</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion</title></titleInfo><name type="personal"><namePart type="given">Alessandro</namePart><namePart type="family">Testori</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</affiliation><affiliation>Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy. Fax: +39‐0294379230===</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Cornelis</namePart><namePart type="family">Verhoef</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Erasmus University MC, Rotterdam, the Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hidde M.</namePart><namePart type="family">Kroon</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Rijnland Hospital, Leiderdorp, the Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Pennacchioli</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Mark B.</namePart><namePart type="family">Faries</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alexander M.M.</namePart><namePart type="family">Eggermont</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Cancer Institute Gustave Roussy, Villejuif/Paris‐Sud, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">John F.</namePart><namePart type="family">Thompson</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Melanoma Institute Australia, North Sydney, Australia</affiliation><affiliation>University of Sydney, Sydney, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2011-09-15</dateIssued><dateCaptured encoding="w3cdtf">2011-06-20</dateCaptured><dateValid encoding="w3cdtf">2011-06-21</dateValid><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">4</extent><extent unit="tables">4</extent><extent unit="references">69</extent><extent unit="words">6479</extent></physicalDescription><abstract lang="en">In‐transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option. J. Surg. Oncol. 2011; 104:397–404. © 2011 Wiley‐Liss, Inc.</abstract><subject lang="en"><genre>keywords</genre><topic>melanoma in‐transit metastases</topic><topic>isolated limb perfusion</topic><topic>isolated limb infusion</topic></subject><relatedItem type="host"><titleInfo><title>Journal of Surgical Oncology</title></titleInfo><titleInfo type="abbreviated"><title>J. Surg. Oncol.</title></titleInfo><name type="personal"><namePart type="given">Don</namePart><namePart type="family">Morton</namePart><affiliation>John Wayne Cancer Institute Santa Monica, CA</affiliation></name><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Review Article</topic></subject><identifier type="ISSN">0022-4790</identifier><identifier type="eISSN">1096-9098</identifier><identifier type="DOI">10.1002/(ISSN)1096-9098</identifier><identifier type="PublisherID">JSO</identifier><part><date>2011</date><detail type="title"><title>Seminars in Surgical Oncology: Melanoma</title></detail><detail type="volume"><caption>vol.</caption><number>104</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>397</start><end>404</end><total>8</total></extent></part></relatedItem><identifier type="istex">085ABF07F0C369C4798C9F363CFBF1379CD2546F</identifier><identifier type="DOI">10.1002/jso.22028</identifier><identifier type="ArticleID">JSO22028</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2011 Wiley‐Liss, Inc.</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000375 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000375 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:085ABF07F0C369C4798C9F363CFBF1379CD2546F
|texte= Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion
}}
| This area was generated with Dilib version V0.6.31. |  |